Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply ...

Ceigall India experienced a 9.46% decrease in consolidated profit for the December quarter, totaling Rs 70.8 crore, despite ...

BSE shares experienced a 4% drop ahead of its Q3 FY25 earnings report, which is projected to show substantial revenue and net ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Qualcomm on Wednesday forecast sales and profits above analyst expectations as artificial intelligence features helped fuel ...

Pepperfry’s revenue from operations declined by 30% in FY24, down from Rs 272 crore in FY23, according to its consolidated ...

Shares of Uber Technologies Inc. dropped 8% in trading today after the company reported better-than-anticipated revenue for ...

Milwaukee-based Harley-Davidson Inc. saw its fourth quarter revenue drop by $365 million, leaving its full year of sales down ...

(Reuters) -Bristol Myers Squibb on Thursday posted better-than-expected fourth-quarter earnings, but said its 2025 revenue ...